Related references
Note: Only part of the references are listed.Total Synthesis of Bryostatin 1
Gary E. Keck et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Molecular Modeling, Total Synthesis, and Biological Evaluations of C9-Deoxy Bryostatin 1
Gary E. Keck et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Probing the Biology of Natural Products: Molecular Editing by Diverted Total Synthesis
Alex M. Szpilman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Bryostatins: biological context and biotechnological prospects
Amaro E. Trindade-Silva et al.
CURRENT OPINION IN BIOTECHNOLOGY (2010)
Current strategies for diversity-oriented synthesis
Sivaraman Dandapani et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Function-Oriented Synthesis of Simplified Caprazamycins: Discovery of Oxazolidine-Containing Uridine Derivatives as Antibacterial Agents against Drug-Resistant Bacteria
Kensuke Ii et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Rationally Simplified Bistramide Analog Reversibly Targets Actin Polymerization and Inhibits Cancer Progression in Vitro and in Vivo
Syed Alipayam Rizvi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
Rajeev Mehla et al.
PLOS ONE (2010)
Repositioning of an existing drug for the neglected tropical disease Onchocerciasis
Christian Gloeckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemical space as a source for new drugs
Jean-Louis Reymond et al.
MEDCHEMCOMM (2010)
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
Paul M. Barr et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells
S. P. Shaha et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Docking and chemoinformatic screens for new ligands and targets
Peter Kolb et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells
Stacey L. Stang et al.
EXPERIMENTAL HEMATOLOGY (2009)
Synthesis at the molecular frontier
Paul A. Wender et al.
NATURE (2009)
A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblasts
Tapan K. Khan et al.
NEUROBIOLOGY OF DISEASE (2009)
Substitution on the A-Ring Confers to Bryopyran Analogues the Unique Biological Activity Characteristic of Bryostatins and Distinct From That of the Phorbol Esters
Gary E. Keck et al.
ORGANIC LETTERS (2009)
The Bryostatin 1 A-Ring Acetate is Not the Critical Determinant for Antagonism of Phorbol Ester-Induced Biological Responses
Gary E. Keck et al.
ORGANIC LETTERS (2009)
Postischemic PKC activation rescues retrograde and anterograde long-term memory
Miao-Kun Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rationally designed peptide regulators of protein kinase C
Eric N. Churchill et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Function-oriented synthesis, step economy, and drug design
Paul A. Wender et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Efficient synthetic access to a new family of highly potent bryostatin analogues via a prins-driven macrocyclization strategy
Paul A. Wender et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: Bryostatin look-alikes that mimic phorbol ester function
Gary E. Keck et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries
Christopher Cordier et al.
NATURAL PRODUCT REPORTS (2008)
Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches
Barry M. Trost et al.
NATURE (2008)
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinity
Paul A. Wender et al.
ORGANIC LETTERS (2008)
Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV
Paul A. Wender et al.
SCIENCE (2008)
A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC
Jarin Hongpaisan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting the protein kinase C family: are we there yet?
Helen J. Mackay et al.
NATURE REVIEWS CANCER (2007)
Natural products as sources of new drugs over the last 25 years
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Small molecule natural products in the discovery of therapeutic agents: The synthesis connection
Rebecca M. Wilson et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma
JA Ajani et al.
INVESTIGATIONAL NEW DRUGS (2006)
Bryostatin enhancement of memory in Hermissenda
A. M. Kuzirian et al.
BIOLOGICAL BULLETIN (2006)
Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin
PA Wender et al.
ORGANIC LETTERS (2006)
Bryostatin-1: Pharmacology and therapeutic potential as a CNS drug
Miao-Kun Sun et al.
CNS DRUG REVIEWS (2006)
Design and synthesis of a potent phorboxazole C(11-15) acetal analogue
AB Smith et al.
ORGANIC LETTERS (2006)
Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes
HG Menzella et al.
NATURE BIOTECHNOLOGY (2005)
Dual effects of bryostatin-1 on spatial memory and depression
MK Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Potent cytotoxins produced by a microbial symbiont protect host larvae from predation
N Lopanik et al.
OECOLOGIA (2004)
Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCδ-GFP
JL Baryza et al.
CHEMISTRY & BIOLOGY (2004)
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
R Etcheberrigaray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The practical synthesis of a novel and highly potent analogue of bryostatin
PA Wender et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Novel nonkinase phorbol ester receptors: The C1 domain connection
MG Kazanietz
MOLECULAR PHARMACOLOGY (2002)
Evidence for the biosynthesis of bryostatins by the bacterial symbiont Candidatus Endobugula sertula of the bryozoan Bugula neritina
SK Davidson et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions
AC Newton
CHEMICAL REVIEWS (2001)
Biosynthesis of complex polyketides in a metabolically engineered strain of E-coli
BA Pfeifer et al.
SCIENCE (2001)
Target-oriented and diversity-oriented organic synthesis in drug discovery
SL Schreiber
SCIENCE (2000)
Effect of CD40 ligand and other immunomodulators on Pneumocystis carinii infection in rat model
HS Oz et al.
MICROBIAL PATHOGENESIS (2000)
Share Paper
